Keywords: thalidomide, value, multiple, myeloma, celgene, thalomid, been

Thalidomide of value in multiple myeloma

Article | 08 September 1999

Print This

Celgene's Thalomid (thalidomide) has been shown to reduce tumor burdenin patients with multiple myeloma, a serious malignant disease of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in